In order to comprehensively compare the difference of clinical parameters and physio-pathological features between CK19-negative and CK19-positive HCC CK19, we obtained accessible data from published literatures for analysis as shown in Figure 2, 16, 17, 21, 29, 36-39. This evidence concerns the gene KRT19 and hepatocellular carcinoma.